High-throughput droplet-based enzymatic DNA methylome profiling enables single-cell resolution of epigenetic heterogeneity
Science Advances · 2026
DOI: 10.1126/sciadv.aef2844 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Gaojie Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: China National Center for Bioinformation, Beijing 100101, China. Hauptthemen laut MEDLINE: DNA Methylation, Single-Cell Analysis, Epigenesis, Genetic, Epigenome. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, National KeyR&D Program of China.
Abstract (Originalsprache)
DNA methylation is a fundamental epigenetic modification that regulates gene expression, cellular identity, and disease-associated regulatory programs. However, high-throughput single-cell DNA methylation technologies have been limited by DNA degradation, low CpG recovery, and the poor scalability of bisulfite-based methods. Here, we present scEM-seq, a droplet-based single-cell enzymatic methylome sequencing method that integrates barcode ligation within a single emulsification step, followed by postemulsion cytosine-to-uracil conversion. This design substantially reduces DNA loss and enables robust profiling of tens of thousands of single cells per experiment. scEM-seq generates high-quality single-cell methylomes with moderately improved CpG coverage and balanced read utilization compared with other droplet-based microfluidic methods. Applied to peripheral blood mononuclear cells, scEM-seq accurately resolves major immune lineages, and in prostate cancer tissues, it reveals diverse malignant cell states and patient-specific epigenetic and copy number architectures. scEM-seq enables scalable single-cell dissection of epigenetic heterogeneity across diverse biological and disease contexts, broadening the scope of DNA methylation–based studies into cellular regulation and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- China National Center for Bioinformation, Beijing 100101, China.
- Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Department of Pharmacy, Peking University First Hospital, Beijing 100034, China.
- School of Medicine, Nankai University, Tianjin 30071, China.
- Department of Urology, Chinese PLA General Hospital, Beijing 100039, China.
ORCID-Profile: Gaojie Li, Yang Yang, Zhuoran Li, Qi Wang, Ying Wang, Bin Guo, Kunmeng Yang, Ming Tan, Jiacheng Sun, Guangxin Zhang, Shengwei Xiong, Mei Zhang, Zhihua Zhang, Yingying Xie, Yue Shi, Xin Ma, Weimin Ci
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- National KeyR&D Program of China
Zitieren
APA
Li, G., Yang, Y., Li, Z., Wang, Q., Wang, Y., Guo, B., Yang, K., Tan, M., Li, J., Sun, J., Zhang, G., Xiong, S., Zhang, M., Zhang, Z., Xie, Y., Shi, Y., Ma, X., & Ci, W. (2026). High-throughput droplet-based enzymatic DNA methylome profiling enables single-cell resolution of epigenetic heterogeneity. Science Advances. https://doi.org/10.1126/sciadv.aef2844
Vancouver
Li G, Yang Y, Li Z, Wang Q, Wang Y, Guo B, et al. High-throughput droplet-based enzymatic DNA methylome profiling enables single-cell resolution of epigenetic heterogeneity. Science Advances. 2026. doi:10.1126/sciadv.aef2844
BibTeX
@article{Li2026,
author = {Li, Gaojie and Yang, Yang and Li, Zhuoran and Wang, Qi and Wang, Ying and Guo, Bin and Yang, Kunmeng and Tan, Ming and Li, Jinwei and Sun, Jiacheng and Zhang, Guangxin and Xiong, Shengwei and Zhang, Mei and Zhang, Zhihua and Xie, Yingying and Shi, Yue and Ma, Xin and Ci, Weimin},
title = {High-throughput droplet-based enzymatic DNA methylome profiling enables single-cell resolution of epigenetic heterogeneity},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aef2844}
}
EUVIMED